Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kingworld Medicines GroupHKSE:01110 -2.06%43 Days Payable is 68.01 as of Dec. 2025, which is 14% below its 10-year median of 79.27. GuruFocus rates HKSE:01110 with a GF Score™ of 43/100 and a GF Value™ of HK$0.50 (Fairly Valued). The stock has 5 warning signs investors should review. Among 609 Healthcare Providers & Services companies, Kingworld Medicines Group ranks better than 62.56% on this metric.
The historical rank and industry rank for Kingworld Medicines Group's Days Payable or its related term are showing as below:
HKSE:01110'
s Days Payable Range Over the Past 10 Years
Min: 63.9 Med: 79.27 Max: 123.61
Current: 78.12
During the past 13 years, Kingworld Medicines Group's highest Days Payable was 123.61. The lowest was 63.90. And the median was 79.27.
HKSE:01110's Days Payable is ranked better than 62.56% of 609
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs HKSE:01110: 78.12
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kingworld Medicines Group Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, Kingworld Medicines Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kingworld Medicines Group Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kingworld Medicines Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Kingworld Medicines Group's Days Payable falls into.
Kingworld Medicines Group Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Kingworld Medicines Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kingworld Medicines Group (HKSE:01110) has a Days Payable of 68.01 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kingworld Medicines Group and its competitors. This is 14% below median its historical median of 79.27. Over the past decade, Kingworld Medicines Group's Days Payable has ranged from 63.90 to 123.61. According to the industry distribution chart, Kingworld Medicines Group ranks #228 out of 609 companies in the Healthcare Providers & Services industry, placing it in the top 37.4%.
Is Kingworld Medicines Group's Days Payable too high?
Kingworld Medicines Group's current Days Payable of 68.01 is 14% below median its 10-year median of 79.27. Over the past 10 years, this metric has ranged from a low of 63.90 to a high of 123.61. The Healthcare Providers & Services industry median Days Payable is 57.13. Kingworld Medicines Group's value of 68.01 is 19% above this industry median. Based on the distribution chart, Kingworld Medicines Group ranks #228 out of 609 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Kingworld Medicines Group has a GF Score™ of 43/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kingworld Medicines Group's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Kingworld Medicines Group ranks #228 out of 609 companies for Days Payable. This puts Kingworld Medicines Group in the upper half of its industry. The industry median Days Payable is 57.13. Kingworld Medicines Group's value of 68.01 is 19% above this benchmark. Historically, Kingworld Medicines Group's own Days Payable has ranged from 63.90 to 123.61 over the past decade. While the company's 10-year median is 79.27 vs. the industry median of 57.13, Kingworld Medicines Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 609 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kingworld Medicines Group's current Days Payable of 68.01 is 19% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kingworld Medicines Group and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kingworld Medicines Group's current Days Payable is 68.01, which is 14% below median its own 10-year median of 79.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kingworld Medicines Group stock overvalued right now?
Based on GuruFocus' analysis, Kingworld Medicines Group (HKSE:01110) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.50, compared to a current price of HK$0.48 — trading 5% below its estimated fair value. The current Days Payable is 68.01, which is 14% below median its 10-year median of 79.27 and 19% above the Healthcare Providers & Services industry median of 57.13. Kingworld Medicines Group's overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Kingworld Medicines Group (HKSE:01110), the current Days Payable is 68.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kingworld Medicines Group (HKSE:01110) Overvalued in 2026?
Based on GuruFocus' analysis, Kingworld Medicines Group stock appears to be undervalued.
The current stock price of HK$0.48 is trading 5% below its estimated GF Value™ of HK$0.50.
GuruFocus considers Kingworld Medicines Group to be Fairly Valued.
Key valuation signals for HKSE:01110:
Days Payable: 68.01 (14% below median its 10-year median of 79.27)
GF Value™: HK$0.50 vs. price of HK$0.48 (5% below fair value)
Industry Position: 19% above the Healthcare Providers & Services median (#228 of 609)
No single metric tells the full story. See the HKSE:01110 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kingworld Medicines Group Ltd is engaged in the Distribution of pharmaceutical and healthcare products, such as branded imported pharmaceutical and healthcare products in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices carried out in the PRC. It derives the majority of its revenue from the Distribution sales of the pharmaceutical and healthcare products segment.
43GF Score
Get the complete analysis for HKSE:01110
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01110 has been successfully added to your 
